Broadway N M, Saggerson E D
Department of Biochemistry and Molecular Biology, University College London, UK.
FEBS Lett. 1995 Sep 4;371(2):137-9. doi: 10.1016/0014-5793(95)00877-c.
The sulphonylureas glibenclamide and tolbutamide inhibited carnitine acyltransferase activities in rat liver microsomes. Glibenclamide was a more potent inhibitor than tolbutamide. The effect of tolbutamide on the malonyl-CoA-inhibitable transferase was influenced by the phospholipid/detergent environment whereas the effect of glibenclamide was not. Glibenclamide was a more potent inhibitor of the malonyl-CoA-inhibitable transferase than of the malonyl-CoA-insensitive enzyme. The extent of inhibition of the malonyl-CoA-inhibitable transferase by tolbutamide was similar to its effect on VLDL triacylglycerol secretion as reported by Wiggins and Gibbons [Biochem. J. 284 (1992) 457-462] possibly supporting the suggestion that microsomal carnitine acyltransferases are involved in VLDL triacylglycerol assembly/secretion.
磺酰脲类药物格列本脲和甲苯磺丁脲可抑制大鼠肝微粒体中的肉碱酰基转移酶活性。格列本脲的抑制作用比甲苯磺丁脲更强。甲苯磺丁脲对丙二酰辅酶A抑制性转移酶的作用受磷脂/去污剂环境的影响,而格列本脲则不受此影响。与丙二酰辅酶A不敏感的酶相比,格列本脲是丙二酰辅酶A抑制性转移酶更有效的抑制剂。甲苯磺丁脲对丙二酰辅酶A抑制性转移酶的抑制程度与其对极低密度脂蛋白(VLDL)三酰甘油分泌的影响相似,正如Wiggins和Gibbons所报道的那样[《生物化学杂志》284卷(1992年)第457 - 462页],这可能支持了微粒体肉碱酰基转移酶参与VLDL三酰甘油组装/分泌的观点。